WASHINGTON ADVOCACY GROUP

Lobbying for AMGEN INC. · Biotechnology

Filing 1st Quarter - Report

1st Quarter (Jan 1 - Mar 31) 2025 · District of Columbia · Senate · $10,000.00 income · posted Apr 20, 2025

Lobbying activity 1

Health Issues

Monitor healthcare regulations and statutes and educate members of Congress on issues with regard to client's interests

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.